Question

I am a breastfeeding mother and i want to know if it is safe to use INC 424? Is INC 424 safe for nursing mother and child? Does INC 424 extracts into breast milk? Does INC 424 has any long term or short term side effects on infants? Can INC 424 influence milk supply or can INC 424 decrease milk supply in lactating mothers?

Answer by DrLact: About INC 424 usage in lactation

No information is available on the clinical use of INC 424 during breastfeeding. Because INC 424 is 97% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during INC 424 therapy and for 2 weeks after the last dose.

Alternate Drugs

Erlotinib(Unsafe)
Pazopanib(Unsafe)
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Vincristine(Dangerous)
Nilotinib(Unsafe)
Tamoxifen(Dangerous)
Mitoxantrone(Dangerous)
Docetaxel(Dangerous)
Dactinomycin(Dangerous)
Trastuzumab(Unsafe)
Hydroxyurea(Low Risk)
Etoposide(Dangerous)
Nivolumab(Unsafe)
Gemcitabine(Dangerous)
Doxorubicin(Dangerous)
Vinblastine(Dangerous)
Cladribine(Dangerous)
Ipilimumab(Unsafe)
Cyclophosphamide(Dangerous)
Bleomycin(Dangerous)
Imatinib(Unsafe)
Cetuximab(Unsafe)
Cisplatin(Unsafe)
Vinorelbine(Dangerous)
Carboplatin(Dangerous)
Busulfan(Dangerous)
Dacarbazine(Dangerous)
Letrozole(Dangerous)
Paclitaxel(Dangerous)
Exemestane(Dangerous)
Fluorouracil(Dangerous)
Dasatinib(Unsafe)
Alemtuzumab(Low Risk)
Rituximab(Low Risk)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Orlistat(Low Risk)
Nilotinib(Unsafe)
Gemcitabine(Dangerous)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.